CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ANAB — Anaptysbio, Inc
CIK 884546
SAN FRANCISCO, CA
Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,655,587
+$2,969,176 QoQ
Shares Held
202,305
-30.0% QoQ
Ownership
0.695%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ANAB ranks #92 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,655,587 | 202,305 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,686,411 | 192,687 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,631,036 | 198,660 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,321,213 | 206,441 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,488,397 | 157,135 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,850,880 | 153,356 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,198,563 | 166,054 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,370,745 | 160,321 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,891,274 | 155,278 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,294,015 | 146,271 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,102,044 | 144,820 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,568,470 | 143,011 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,839,708 | 139,612 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,250,646 | 149,386 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,612,272 | 148,831 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,711,406 | 145,488 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,890,733 | 142,401 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,516,313 | 142,131 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,736,848 | 136,312 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,678,502 | 135,638 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,703,511 | 142,827 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,925,031 | 135,732 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,061,356 | 142,389 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,084,654 | 141,333 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,473,236 | 155,472 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,152,860 | 152,361 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||